XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Treasury Shares
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Total
Balance (in shares) at Dec. 31, 2023 16,030,172          
Balance (in shares) at Dec. 31, 2023   735,037        
Balance, beginning of period at Dec. 31, 2023 $ 16,030 $ (16,628) $ 144,388 $ 157,028 $ (38,437) $ 262,381
Net income       5,306   5,306
Other comprehensive income (loss), net         (2,269) (2,269)
Cash dividends declared on common stock       (4,283)   (4,283)
Shares issued for dividend reinvestment plan (in shares)   (20,886)        
Shares issued for dividend reinvestment plan   $ 473 (66)     407
Restricted stock granted (in shares)   (72,860)        
Restricted stock granted   $ 1,646 (1,646)     0
Forfeiture of restricted stock (in shares)   587        
Forfeiture of restricted stock   $ (14) 14     0
Stock-based compensation expense     326     326
Purchase of restricted stock for tax withholding (in shares)   10,229        
Purchase of restricted stock for tax withholding   $ (212)       (212)
Balance (in shares) at Mar. 31, 2024 16,030,172          
Balance (in shares) at Mar. 31, 2024   652,107        
Balance, end of period at Mar. 31, 2024 $ 16,030 $ (14,735) 143,016 158,051 (40,706) $ 261,656
Balance (in shares) at Dec. 31, 2024 16,030,172          
Balance (in shares) at Dec. 31, 2024   596,678       596,678
Balance, beginning of period at Dec. 31, 2024 $ 16,030 $ (13,328) 143,565 165,778 (36,761) $ 275,284
Net income       6,293   6,293
Other comprehensive income (loss), net         4,071 4,071
Cash dividends declared on common stock       (4,330)   (4,330)
Shares issued for dividend reinvestment plan (in shares)   (18,391)        
Shares issued for dividend reinvestment plan   $ 411 (15)     396
Restricted stock granted (in shares)   (42,961)        
Restricted stock granted   $ 959 (959)     0
Forfeiture of restricted stock (in shares)   2,265        
Forfeiture of restricted stock   $ (52) 52     0
Stock-based compensation expense     325     325
Purchase of restricted stock for tax withholding (in shares)   9,733        
Purchase of restricted stock for tax withholding   $ (208)       $ (208)
Balance (in shares) at Mar. 31, 2025 16,030,172          
Balance (in shares) at Mar. 31, 2025   547,324       547,324
Balance, end of period at Mar. 31, 2025 $ 16,030 $ (12,218) $ 142,968 $ 167,741 $ (32,690) $ 281,831